Delve Health and AliveCor Collaborate to Revolutionize Digital Healthcare Solutions in Cardiology



MINNEAPOLIS, Feb. 7, 2024 /PRNewswire/ — Delve Health, a leading innovator in digital healthcare and decentralized clinical trial biotechnology, is excited to announce a collaboration with AliveCor, to integrate its KardiaMobile® 6L, the world’s most clinically-validated personal electrocardiogram (EKG) device, within the LiveCare Link + smart RPM gateway. The partnership is expected to foster new research initiatives, accelerate drug development processes, and open possibilities for innovative treatments that can address unmet medical needs. By driving increased efficiencies and precision in healthcare, the collaboration seeks to make a lasting impact on patients’ lives and contribute to a healthier society.

Delve Health’s integration of AliveCor’s KardiaMobile 6L device offers a unique opportunity to improve the health outcomes of patients with cardiac conditions. By using the KardiaMobile 6L device, patients and healthcare professionals can monitor their heart rhythm and detect abnormalities such …

Full story available on


Leave a Reply

Your email address will not be published. Required fields are marked *